Spirometer flow sensor market seen reaching $1.55B by 2030

The spirometer flow sensor market is projected to grow from $1 billion in 2025 to $1.55 billion by 2030, driven by respiratory disease rates, telemedicine adoption and connected diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - The market underpins respiratory testing used to detect and monitor lung disease. - Growth reflects rising demand for remote monitoring, home care and more precise digital diagnostics. - The category could benefit from wider use of connected medical devices in healthcare systems.

What happened: - The spirometer flow sensor market reached an estimated $1 billion in 2025 and is projected to rise to $1.09 billion in 2026. - The Business Research Company forecasts the market will hit $1.55 billion by 2030. - The report projects an 8.8% CAGR from 2025 to 2026 and 9.1% CAGR from 2026 to 2030. - The report was published July 22, 2026. - Download a free sample of the market report. - View the full market report.

The details: - A spirometer flow sensor measures the volume and speed of air inhaled and exhaled. - The sensor converts airflow variations into electrical signals for respiratory analysis. - The report cites chronic respiratory illness, broader pulmonary function testing and early lung disease detection as historical growth drivers. - The report cites remote respiratory monitoring, home healthcare, telemedicine, AI-enhanced diagnostic precision, preventive screening and connected medical devices as forecast-period drivers. - Leading trends include AI-powered respiratory diagnostics, IoT-enabled sensors, cloud-based pulmonary function testing platforms, portable and handheld spirometry devices, and high-accuracy digital airflow measurement tools. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report highlights market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - Rising respiratory disease burden is a direct demand driver because these sensors help clinicians measure airflow and track disease progression. - Higher healthcare spending likely supports adoption because hospitals and health systems can fund more advanced diagnostic equipment. - The report points to a shift from clinic-only testing toward continuous and home-based respiratory monitoring. - UK data cited in the report show tuberculosis cases rose 13% in England in 2024 to 5,480 from 4,850 in 2023. - UK total healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, according to the Office for National Statistics. - Government-funded healthcare spending in the UK reached $328 billion (£258 billion) in 2024, a 2.5% real-term increase.

What's next: - The market’s next phase of growth will likely depend on how quickly providers adopt remote monitoring and AI-based diagnostics. - Product development is likely to keep favoring portable, connected and higher-accuracy sensors for clinical and home use. - Asia-Pacific could narrow the gap with North America if healthcare investment and digital diagnostics adoption continue to accelerate.